Top Strategies To Reduce Off-Target Effects For Safer Genome Editing
Source: Cell & Gene
Genome editing holds immense promise for treating genetic diseases, but off-target effects remain a significant concern. To ensure the safety and efficacy of genome editing therapies, researchers are developing various strategies to reduce off-target effects.
Cell & Gene's Erin Harris welcomed Steve Kanner, Ph.D., CSO at Caribou Biosciences, and Eric Clark, Ph.D., Life Sciences Management Consultant at Accenture, for a discussion on the strengths and limitations of gene editing systems and the strategies to improve the safety of off-target assessment.
Available on-demand thanks to the support of Bio-Techne.
Don't have time to watch the full video? Check out these segments by topic:
- An Off-Target Effect in Genome Editing Defined
- How to Reduce Off-Target Effects of Genome Editing
- How to Control for Off-Target Effects of Genome Editing
- Inside Enhanced Delivery Systems For Genome Editing
- A Deep Dive Into CRISPR-Cas9
- Phenotypic Effects and Editing The Human Germ Line
- Top Strategies To Reduce Off-Target Effects For Safer Genome Editing | Audience Questions
This website uses cookies to ensure you get the best experience on our website. Learn more